Skip to content
Directory

Andrea Burke, DMD, MD

Andrea Burke

Associate Professor
Oral and Maxillofacial Surgery

Academic: 206-543-7722
Clinical Contact: Harborview Medical Center. 206-744-3224

abburke@uw.edu

Burke
Dr. Andrea Burke is an Associate Professor in the Department of Oral and Maxillofacial Surgery. Dr. Burke joined the Oral and Maxillofacial Surgery team at the University of Washington after completing the Dental Clinical Research Fellowship Program at the National Institute of Dental and Craniofacial Research, National Institutes of Health, in Bethesda, MD. She trained in Oral and Maxillofacial Surgery at the Massachusetts General Hospital in Boston, MA, and obtained her D.M.D. and M.D. degrees from Harvard University. Dr. Burke is a Diplomate of the American Board of Oral and Maxillofacial Surgery. She practices the full scope of Oral and Maxillofacial Surgery, with a special interest in skeletal diseases.

  • 1997-2001    B.A., Major in Biology, Minor in Environmental Science; Barnard College, Columbia University
  • 2003-2007    D.M.D., Harvard School of Dental Medicine
  • 2007-2010    M.D., Harvard Medical School
  • 2013-2016 Clinical Research Fellow, National Institute of Dental and Craniofacial Research, NIH
Dr. Burke’s clinical and research interests include the pathophysiology of skeletal diseases, such as fibro-osseous and giant cell lesions, osteonecrosis of the jaws and odontogenic tumors.  Her current research focuses on the molecular and genetic understanding of benign craniofacial fibro-osseous lesions.  She also helped to create the first Fibrous Dysplasia/McCune-Albright Syndrome Patient Registry.
  1. Foster BL, Ramnitz MS, Gafni RI, Burke AB, Boyce AM, Lee JS, Wright JT, Akintoye SO, Somerman MJ, Collins MT. “Rare Bone Diseases and Their Dental, Oral, and Craniofacial Manifestations.  J Dent Res. 2014 Apr 3;93 (7 suppl):7S-19S.
  2. Boyce AM, Burke A, Peck C, DuFresne CR, Lee JS, Collins MT. Surgical management of polyostotic craniofacial fibrous dysplasia: long-term outcomes and predictors for post-operative regrowth.”  Plastic and Reconstructive Surgery. 2016 Jun;137(6):1833-9.
  3. Burke, A.B., Boyce, A.M., Collins, M.T. Response to “Fibrous Dysplasia: Management of the Optic Canal.”  Plastic and Reconstructive Surgery. Advance online publication 2016 Jun;137(6).
  4. Metwally, T., Burke, A.B., Tsai, J.Y., Boyce, A.M. “Fibrous dysplasia and bisphosphonate-related osteonecrosis of the jaw.”  Journal of Oral and Maxillofacial Surgery, 2016 Sep;74(9):1765-70.
  5. Burke, A.B., Collins, M.T., Boyce, A.M. “Invited Medical Review: Fibrous Dysplasia of Bone: Craniofacial and Dental Implications.”  Oral Diseases.  2016 Aug 5. doi: 10.1111/odi.12563.
  6. Lim, Y.H.*, Burke, A.B.,* Ramnitz, M.S., Collins, M.T., Choate, K.A. “Multilineage ACTB mutation in a patient with fibro-osseous maxillary lesion and astrocytoma.” American Journal of Medical Genetics.  2018 Sep; 176(9): 2037-2040.   * first authors contributed equally
  7. Burke, A.B., Cheng, K.L., Han J.T., Dillon, J.K., Dodson, T.B., Susarla, S.M. “Is gender associated with success in academic oral and maxillofacial surgery?” Journal of Oral & Maxillofacial Surgery. 2019 Feb; 77(2): 240-246.
  8. F. de Castro*, A.B. Burke*, H.D. Wang, J. Tsai, P. Florenzano, K.S. Pan, N. Bhattacharyya, A.M. Boyce, R.I. Gafni, A.A. Molinolo, P.G. Robey, M.T. Collins. “Activation of RANK/RANKL/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden.”  Journal of Bone and Mineral Research.  2019 Feb; 34(2): 290-294.   * first authors contributed equally
  9. Zurayk, L., Cheng, K., Zemplenyi, M., Burke, A.B., Dillon, J.K. “Perceptions of Sexual Harassment in Oral and Maxillofacial Surgery Training and Practice”  Journal of Oral and Maxillofacial Surgery.  2019 Aug 29.  doi: 10.1016/j.joms.2019.08.019.
  10. Mishra, R., Burke, A., Gitman, B., Verma, P., Engelstad, M., Haendel, M., Alevizos, I., Gahl, W.A., Collins, M.T., Lee, J.S., Sincan, M. “Data-driven method to enhance craniofacial and oral phenotype vocabularies.” Journal of the American Dental Association. 2019 Nov; 150(11): 933-939.e2.
  11. Burke, A.B. “2020 ACOMS Elaine A. Stuebner Scholars Award Winning Essay: Creating the ‘Women in Oral and Maxillofacial Surgery Pipeline.'” Oral Surg Oral Med Oral Pathol Oral Radiol.  2020 May; 129(5):428-430.
  12. Raborn, L.N., Burke, A.B., Ebb, D.H., Collins, M.T., Kaban, L.B., Boyce, A.M.”Denosumab for Craniofacial Fibrous Dysplasia: Duration of Efficacy and Post-Treatment Effects.” Osteoporosis International. Published online March 27, 2021. DOI: https://doi.org/10.1007/s00198-021-05895-6.
  1. Burke, A.B., Somerman, M., Lee, J.S. “A Career as a Surgeon-Scientist,” in Careers in Oral and Maxillofacial Surgery, Oral and Maxillofacial Surgery, 3rd Edition. Raymond J. Fonseca, Robert D. Marciani, Timothy A. Turvey.  St. Louis:  Saunders, 2017.
  2. Burke, A.B. and Mishra, R. “Bone Diseases,” in Translational Systems Medicine and Oral Disease.  Stephen Sonis and Allejandro Villa.  London, UK:  Elsevier Academic Press.
  3. Lee, J.S., Burke, A.B. ” Biology of bone and cartilage grafting.” in Aesthetic Surgery of the Facial Skeleton.  Baker, Patel, Weinzweig.    In press, March 15, 2021.
  1. B. Burke, A. Boyce. “The Search for a Blood Test to Diagnose and Assess the Effectiveness of Treatment in Vascular Malformations.”  Inaugural International Lymphangiomatosis & Gorham’s Disease Alliance Patient-Family Conference.  June 2014, Houston, TX.
  2. B. Burke, H.D. Wang, J. Tsai, N. Bhattacharyya, A.M. Boyce, R.I. Gafni, A. Estrada, A.A. Molinolo, K. Holmbeck, V. Kram, P.G. Robey, M.T. Collins. ““RANKL Inhibition in the Pathogenesis and Treatment of Fibrous Dysplasia.”  American Society of Bone and Mineral Research Annual Meeting and the National Bone Health Alliance/Rare Bone Disease Patient Network Workshop: Mechanistic and Therapeutic Insights into Skeletal Biology Learned from the Study of Rare Bone Diseases.  September  2014, Houston, TX.
  3. B. Burke. “Surgical Treatment of Craniofacial Fibrous Dysplasia: A Case Report and Review.”  National Institute of Dental and Craniofacial Research Clinical Case Conference.  May 2015, Bethesda, MD.
  4. B. Burke. “Craniofacial Fibro-osseous Lesions:  The good, the bad and the osteoclast.” Craniofacial and Skeletal Diseases Branch Seminar, National Institute of Dental and Craniofacial Research.  June 2015, Bethesda, MD.
  5. B. Burke, A.M. Boyce, C. Cutler-Peck, C. DuFresne, J.S. Lee, M.T. Collins. “Long-term outcomes of surgical treatment for craniofacial fibrous dysplasia.” American Association of Oral and Maxillofacial Surgeons Annual Meeting, Washington, D.C., September 2015.
  6. B. Burke. “Translating the effects of RANKL inhibition in the treatment of fibrous dysplasia of bone.” Craniofacial and Skeletal Diseases Branch Seminar, National Institute of Dental and Craniofacial Research. April 2016, Bethesda, MD.
  7. B. Burke, A.M. Boyce, M.T. Collins. ““Dental Findings from the National Institutes of Health Fibrous Dysplasia/McCune-Albright Syndrome Cohort.” American Society of Bone and Mineral Research Annual Meeting.  September 2016, Atlanta, GA.
  8. B. Burke. “Fibrous Dysplasia: Craniofacial and Dental Implications”  The MAGIC Foundation 2017 Annual Convention.  July 2017, Lombard, IL.
  9. B. Burke. “The Role of Bisphosphonates and Antiangiogenics in Fibro-osseous Lesions.” American Association of Oral & Maxillofacial Surgeons Women’s Special Interest Group, Inaugural Meeting.  October 2017, San Francisco, CA.
  10. B. Burke & J.S. Lee. “Fibrous Dysplasia: Craniofacial and Dental Implications.”  Annual Fibrous Dysplasia/McCune-Albright Syndrome Patient and Family Conference.  Sponsor:  Fibrous Dysplasia Foundation.   November 2017, Silver Spring, MD.
  11. B. Burke “RANKL Inhibition in the Pathogenesis and Treatment of Fibrous Dysplasia.”  Oral Health Sciences Seminar, University of Washington School of Dentistry.  April  2018, Seattle, WA.
  12. F. de Castro, A.B. Burke, H.D. Wang, J. Tsai, P. Florenzano, K.S. Pan, N. Bhattacharyya, A.M. Boyce, R.I. Gafni, A.A. Molinolo, P.G. Robey, M.T. Collins. “Activation of RANK/RANKL/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden.”  American Society of Bone and Mineral Research Annual Meeting, Montreal, QC, Canada, September 2018.
  13. B. Burke, K.L. Cheng, J.T. Han, J.K. Dillon, T.B. Dodson, S.M. Susarla. “Is gender associated with success in academic oral and maxillofacial surgery?” American Association of Oral and Maxillofacial Surgeons Annual Meeting, Chicago, IL, October 2018.
  14. B. Burke, A. M. Boyce, D. Ebb, M.T. Collins, L.B. Kaban. “Successful Use of Denosumab to Manage Pain and Prevent Postoperative Regrowth of Craniofacial Fibrous Dysplasia.”  American Association of Oral and Maxillofacial Surgeons Annual Meeting, Chicago, IL, October 2018.
  15. B. Burke. “Approach to the Patient with an Unknown Fibro-osseous Lesion.”  American College of Oral and Maxillofacial Surgeons Annual Meeting, Santa Fe, NM.  April 2019.
  16. Zurayk, L., Cheng, K., Zemplenyi, M., Burke, A.B., Dillon, J.K. “Perceptions of Sexual Harassment in Oral and Maxillofacial Surgery Training and Practice.”  American Association of Oral & Maxillofacial Surgeons Annual Meeting – Joint Meeting with Dutch Society of Oral and Maxillofacial Surgeons, Boston, MA, September 2019.
  17. B. Burke. “Phosphaturic Mesenchymal Tumor: The one that almost got away.”  Oral and Maxillofacial Surgery Grand Rounds, University of Washington School of Dentistry, December 2019.
  18. B. Burke. ” Applications of Endoscopy in Oral and Maxillofacial Surgery.”  Oral and Maxillofacial Surgery Grand Rounds, University of Washington School of Dentistry (Zoom Meeting), September 2020.
  19. B. Burke. “Developing the ‘Women in Oral and Maxillofacial Surgery Pipeline.'”  American Dental Education Association (ADEA) National Meeting (virtual), March 2021.